Form 10-Q UNITED THERAPEUTICS Corp For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
United Therapeutics (UTHR) Tops Q3 EPS by 120c
October 27, 2015 6:24 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.55, $1.20 better than the analyst estimate of $2.35. Revenue for the quarter came in at $386.2 million versus the consensus estimate of $363.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
... More